ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
150 hedge funds and large institutions have $2.38B invested in Intercept Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
6% less funds holding
Funds holding: 159 → 150 (-9)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
150
Holding in Top 10
–
Calls
$105M
Puts
$80.2M
Top Buyers
| 1 | +$121M | |
| 2 | +$68.9M | |
| 3 | +$43.3M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$9.61M |
| 5 |
Goldman Sachs
New York
|
+$9.25M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$11.3M | |
| 3 | -$10.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.2M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$10M |